849805-79-4

Usage

Uses

Used in Pharmaceutical Industry:
2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid is used as a chemical compound for the development of new drugs. Its potential applications include antiviral and antibacterial agents, as well as treatments for neurological disorders. 2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID's unique structure and properties make it a valuable candidate for further research and development in medicinal chemistry.
Used in Antiviral Applications:
2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid is used as an antiviral agent for its potential to inhibit viral replication and reduce the severity of viral infections. Its effectiveness in this application is currently under investigation.
Used in Antibacterial Applications:
2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid is used as an antibacterial agent for its potential to combat bacterial infections. It is being studied for its ability to disrupt bacterial cell functions and inhibit bacterial growth, which could lead to the development of new antibiotics.
Used in Neurological Disorders Treatment:
2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid is used as a potential treatment for neurological disorders due to its potential to modulate neural pathways and improve neurological function. It is being researched for its potential to alleviate symptoms and improve the quality of life for patients suffering from various neurological conditions.

Upstream product

• 267413-07-0 3,4-dihydro-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile 
• 115170-40-6 7-aza-5-bromoindoline 
• 10592-27-5 7-azaindoline 

Relevant academic research and scientific papers

15-PGDH INHIBITOR

[Problem] To provide a compound having a 15-PGDH inhibitory effect. [Solution] A compound represented by general formula (1) or a pharmacologically acceptable salt thereof.

Histone deacetylase inhibitors and its preparation method and use thereof

The invention discloses a histone deacetylase inhibitor and its preparation method and use, the invention discloses a compound of the formula I as shown, or its crystalline form, or its pharmaceutically acceptable salt, or solvate thereof, or prodrug thereof, or its metabolic product. The invention of the formula I illustrated new compound, has shown good deacetylase inhibition activity, with the histone deacetylase for clinical treatment of diseases associated with abnormal activity of a new pharmaceutical may be.

NOVEL ANTIMALARIA AGENT CONTAINING HETEROCYCLIC COMPOUND

Disclosed is an antimalarial agent containing a compound represented by the formula: [wherein A1 represents a 3-pyridyl group that may have a substituent, a 6-quinolyl group that may have a substituent, or the like; X1 represents a group represented by the formula -C(=O)-NH- or the like; E represents a furyl group, a thienyl group or a phenyl group; with the proviso that A1 may have one to three substituents, and E has one of two substituents] or a salt thereof or hydrates thereof.

NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND

The present invention provides an antifungal agent represented by the formula: [wherein A1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X1 represents a group represented by the formula -NH-C(=O)-, a group represented by the formula -C(=O)-NH-, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A1 may have 1 to 3 substituents, and E has one or two substituents].